EUVIMEDEUVIMED entdecken
Open Access

An ULK1/2‐PXN mechanotransduction pathway suppresses breast cancer cell migration

Peigang Liang iD, Jiaqi Zhang, Yuchen Wu, Shanyuan Zheng, Zhaopeng Xu iD, Shuo Yang, Jinfang Wang, Suibin Ma, Li Xiao, Tianhui Hu, Wenxue Jiang, Chaoqun Huang iD und 3 weitere

The EMBO Reports · 06.11.2023 · 24 (11)

DOI: 10.15252/embr.202356850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The EMBO Reports, online erschienen am 17.10.2023. Verfasst von Peigang Liang und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, China. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIMH NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemalePaxillinMechanotransduction, CellularPhosphorylationCell MovementSerineAutophagy-Related Protein-1 HomologIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

PXN/PaxillinULK1/2breast cancer cell migrationfocal adhesionsmechanotransduction

Substanzen

PaxillinSerineULK1 protein, humanAutophagy-Related Protein-1 HomologIntracellular Signaling Peptides and ProteinsPXN protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, China.
  • Department of Oncology, Zhongshan Hospital of Xiamen University, Xiamen, China.
  • Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China.
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hu…
  • Central Laboratory, The Fifth Hospital of Xiamen, Xiamen, China.
  • Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

ORCID-Profile: Peigang Liang, Zhaopeng Xu, Chaoqun Huang, Qiong Xing, Mondira Kundu, Bo Wang

Förderung

  • NIGMS NIH HHS
  • NIMH NIH HHS
  • NIH HHS
  • GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province
  • HHS | National Institutes of Health
  • MOST | National Key Research and Development Program of China
  • MOST | National Natural Science Foundation of China

Zitieren

APA

Liang, P., Zhang, J., Wu, Y., Zheng, S., Xu, Z., Yang, S., Wang, J., Ma, S., Xiao, L., Hu, T., Jiang, W., Huang, C., Xing, Q., Kundu, M., & Wang, B. (2023). An ULK1/2‐PXN mechanotransduction pathway suppresses breast cancer cell migration. The EMBO Reports, 24(11). https://doi.org/10.15252/embr.202356850

Vancouver

Liang P, Zhang J, Wu Y, Zheng S, Xu Z, Yang S, et al. An ULK1/2‐PXN mechanotransduction pathway suppresses breast cancer cell migration. The EMBO Reports. 2023;24(11). doi:10.15252/embr.202356850

BibTeX
@article{Liang2023,
  author = {Liang, Peigang and Zhang, Jiaqi and Wu, Yuchen and Zheng, Shanyuan and Xu, Zhaopeng and Yang, Shuo and Wang, Jinfang and Ma, Suibin and Xiao, Li and Hu, Tianhui and Jiang, Wenxue and Huang, Chaoqun and Xing, Qiong and Kundu, Mondira and Wang, Bo},
  title = {An ULK1/2‐PXN mechanotransduction pathway suppresses breast cancer cell migration},
  journal = {The EMBO Reports},
  year = {2023},
  volume = {24},
  number = {11},
  doi = {10.15252/embr.202356850}
}
Kostenlos starten →